Chair: @KevinBaskin
Scribe: @JuliaSkapik
Call Info:
Join the online meeting: https://join.freeconferencecall.com/cic-cc
PLEASE USE COMPUTER AUDIO
VANGUARD ON CONFLUENCE: https://confluence.hl7.org/pages/viewpage.action?pageId=51226195
NOTE: This attendance applies if you are present at the related meeting/call, regardless if you have signed a different attendance for your WG.
Attendees
Present | Name | Affiliation |
|---|---|---|
@JuliaSkapik | ||
| @KevinBaskin | ||
| Lindsey Hoggle | ||
| Laura Heermann-Langford | ||
Minutes Approved as Presented
This is to approve minutes via general consent. "You have received the minutes. Are there any corrections to the minutes? (pause) Hearing none, if there are no objections, the minutes are approved as printed."
Agenda Topics
Agenda Outline | Agenda Item | Meeting Minutes from Discussion | Decision Link(if not child) |
|---|---|---|---|
| Management | Call management, Minute approval | 2020-03-19 Vanguard March Conference Call | |
| VANGUARD PSS | VANGUARD CRN is working on developing standardized vocabulary in the vascular access (especially chronic central venous access) domain, across all stakeholders. | ||
| COVID-19 Response | Infrastructure that will identify COVID-19 contacts and improve containment of infectious transmission. See notes below | See Executive Summary.VA Proposal Executive Summary.docx | |
| Pilot post-market surveillance study for venous catheter lock-flush solutions | |||
| Next Call | Tasks for follow up | ||
| Adjournment | Adjourned at |
Supporting Documents
Outline Reference | Supporting Document |
|---|---|
| Minute Approval | |
___________________________________________________________________________________________________________________________________________________________________________________
Introduction to VANGUARD Working Group:
Dear Colleagues,
Please join us for our first HL7 call for the VANGUARD Coordinated Registry Network. The purpose of this call will be introductory.
VANGUARD CRN is working on developing standardized vocabulary in the vascular access (especially chronic central venous access) domain, across all stakeholders. There is an approved HL7 PSS, with sponsorship from CIC and co-sponsorship from CIMI.
VANGUARD is also working with a coalition to evolve an infrastructure that will identify COVID-19 contacts and improve containment of infectious transmission.
This solution relies heavily on a quantum privacy network and data access authorization. It will make use of data sourcing from CDC, state and local health authorities, and the Veterans Administration as well as other relevant data repositories containing identities of known COVID-19-infected individuals (index cases). Project partners will construct secure link relationships for these index cases, and search persistence links with potential contacts.
The system will communicate with potential contacts with higher risk profiles. Communication includes notification of potential contact risk, education regarding contact risk, and recommendations for risk mitigation (extreme social distancing, self-quarantine, testing, etc.).
The system will also enroll and consent potential contacts, requesting various levels of access to contact health data relevant to suspicious signs and symptoms, co-morbidities, and other factors that may increase likelihood of infection, risk of complicated infection, and risk of re-transmission.
Reporting of high-risk potential contacts to health authorities and heat map analysis will assist tracking of patterns of transmission and direct appropriate resources and response.
Kind regards,
Kevin
Kevin M. Baskin, MD
CEO, VANGUARD Medical Systems
__________________________________________________________________________________________________________________________________________________________